» Articles » PMID: 38008103

Mycoplasma Pneumoniae: Delayed Re-emergence After COVID-19 Pandemic Restrictions

Overview
Journal Lancet Microbe
Date 2023 Nov 26
PMID 38008103
Authors
Affiliations
Soon will be listed here.
Citing Articles

Neutrophils are involved in the development and outcomes of plastic bronchitis associated with Mycoplasma pneumoniae pneumonia.

Huang X, Qin H, Zhang R, Jia X, Zhao D, Liu F Respir Res. 2025; 26(1):92.

PMID: 40057734 PMC: 11890523. DOI: 10.1186/s12931-025-03167-z.


Re-emergence of Mycoplasma pneumoniae before and after COVID-19 pandemic in Germany.

Waldeck F, Kramer T, Boutin S, Matten J, Kramer J, Rupp J BMC Infect Dis. 2025; 25(1):318.

PMID: 40050786 PMC: 11884198. DOI: 10.1186/s12879-025-10657-4.


Reactive Infectious Mucocutaneous Eruption (RIME) in an Adult Male With Mycoplasma pneumoniae: A Case Report.

Alawad S, Alsaeed N, Burnette B, Colantonio M, Kasson L Cureus. 2025; 17(1):e78301.

PMID: 40026955 PMC: 11872188. DOI: 10.7759/cureus.78301.


Macrolide-Resistant Mycoplasma pneumoniae Infections among Children after COVID-19 Pandemic, Ohio, USA.

Leber A, Embry T, Everhart K, Taveras J, Oyeniran S, Wang H Emerg Infect Dis. 2025; 31(3):555-558.

PMID: 40023809 PMC: 11878328. DOI: 10.3201/eid3103.241570.


Clinical Characteristics and Treatment Outcomes of Pediatric Drug-Resistant Pneumonia in the Post-COVID-19 Era.

Sun Q, Hao J, Zhou Q, Zeng Y Infect Drug Resist. 2025; 18:957-963.

PMID: 39990785 PMC: 11846524. DOI: 10.2147/IDR.S502937.